Results 11 to 20 of about 224,268 (252)

[Chronic coronary syndrome].

open access: yesUgeskrift for laeger, 2021
In the 2019 European Society of Cardiology guidelines, chronic coronary syndrome (CCS) was introduced as a new term for stable coronary artery disease. Diagnosis, treatment and prevention of CCS have undergone major changes. In the diagnostic management of CCS, there is increased focus on non-invasive imaging modalities, including coronary CT ...
Tine Glavind Bülow, Pedersen   +5 more
  +6 more sources

Coronary Magnetic Resonance Angiography in Chronic Coronary Syndromes [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2021
Cardiovascular disease is the leading cause of mortality worldwide, with atherosclerotic coronary artery disease (CAD) accounting for the majority of cases. X-ray coronary angiography and computed tomography coronary angiography (CCTA) are the imaging modalities of choice for the assessment of CAD.
Reza Hajhosseiny   +10 more
openaire   +4 more sources

Gut Microbiome in Chronic Coronary Syndrome Patients [PDF]

open access: yesJournal of Clinical Medicine, 2021
Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. Therefore, new factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated.
Emilia Sawicka-Smiarowska   +30 more
openaire   +3 more sources

Colchicine for acute and chronic coronary syndromes [PDF]

open access: yesHeart, 2020
Colchicine is an ancient drug, traditionally used for the treatment and prevention of gouty attacks; it has become standard of treatment for pericarditis with a potential role in the treatment of coronary artery disease. Atherosclerotic plaque formation, progression, destabilisation and rupture are influenced by active proinflammatory cytokines ...
Massimo Imazio   +4 more
openaire   +3 more sources

Layered plaque in patients with chronic coronary syndrome. [PDF]

open access: yesAtheroscler Plus
Plaque disruption exposes thrombogenic substrates and triggers local thrombosis. When a fresh thrombus forms, endogenous antithrombotic mechanisms activate. The balance between these two pro- and antithrombotic mechanisms determines the outcome of plaque disruption. When thrombogenic stimuli outweigh the antithrombotic mechanisms, an occlusive thrombus
Mito T   +11 more
europepmc   +4 more sources

The Incremental Role of Coronary Computed Tomography in Chronic Coronary Syndromes [PDF]

open access: yesJournal of Clinical Medicine, 2020
In the context of chronic coronary syndromes (CCS), coronary computed tomography angiography (CCTA) has gained broad acceptance as a noninvasive anatomical imaging tool with ability of excluding coronary stenosis with strong negative predictive value.
Francesca Baessato   +12 more
openaire   +4 more sources

Chronic coronary syndrome with suspected Takayasu's arteritis. [PDF]

open access: yesEur Heart J Imaging Methods Pract
Złahoda-Huzior A   +6 more
europepmc   +4 more sources

The Role of Uric Acid in Acute and Chronic Coronary Syndromes [PDF]

open access: yesJournal of Clinical Medicine, 2021
Uric acid (UA) is the final product of the catabolism of endogenous and exogenous purine nucleotides. While its association with articular gout and kidney disease has been known for a long time, new data have demonstrated that UA is also related to cardiovascular (CV) diseases.
Alessandro Maloberti   +16 more
openaire   +4 more sources

Inflammatory response to elective percutaneous coronary intervention is related to myocardial injury [PDF]

open access: yesEinstein (São Paulo)
Introduction: In acute coronary syndrome, the release of inflammatory and myocardial injury biomarkers after percutaneous coronary intervention is associated with poor prognosis.
Priscilla Teixeira Céo Frisso   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy